Hepatocellular carcinoma
Top Cited Papers
- 1 March 2012
- journal article
- research article
- Published by Elsevier BV in The Lancet
- Vol. 379 (9822), 1245-1255
- https://doi.org/10.1016/s0140-6736(11)61347-0
Abstract
No abstract availableFunding Information
- the Instituto de Salud Carlos III ((PI 08/0146))
- the US National Institutes of Health-NIDDK (1R01DK076986-01)
- National Institute of Health (Spain) grant I+D Program ((SAF-2007-61898))
This publication has 120 references indexed in Scilit:
- Recommendations for liver transplantation for hepatocellular carcinoma: an international consensus conference reportThe Lancet Oncology, 2012
- Combining Clinical, Pathology, and Gene Expression Data to Predict Recurrence of Hepatocellular CarcinomaGastroenterology, 2011
- Management of hepatocellular carcinoma: An updateJournal of Hepatology, 2011
- Incidence of hepatocellular carcinoma in chronic hepatitis B patients receiving nucleos(t)ide therapy: A systematic reviewJournal of Hepatology, 2010
- Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008International Journal of Cancer, 2010
- Prospective Randomized Study of Doxorubicin-Eluting-Bead Embolization in the Treatment of Hepatocellular Carcinoma: Results of the PRECISION V StudyCardioVascular and Interventional Radiology, 2009
- Trends in mortality from hepatocellular carcinoma in Europe, 1980‐2004Journal of Hepatology, 2008
- Hepatocellular carcinoma pathogenesis: from genes to environmentNature Reviews Cancer, 2006
- Randomized controlled trial of screening for hepatocellular carcinomaZeitschrift für Krebsforschung und Klinische Onkologie, 2004
- Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trialThe Lancet, 2002